ID

34562

Description

Biomarkers of Remission in Rheumatoid Arthritis (BioRRA); ODM derived from: https://clinicaltrials.gov/show/NCT02219347

Lien

https://clinicaltrials.gov/show/NCT02219347

Mots-clés

  1. 19/01/2019 19/01/2019 -
  2. 15/04/2020 15/04/2020 -
  3. 16/04/2020 16/04/2020 - Sarah Riepenhausen
Détendeur de droits

see on clinicaltrials.gov

Téléchargé le

19 janvier 2019

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Rheumatoid Arthritis NCT02219347

Eligibility Rheumatoid Arthritis NCT02219347

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
clinical diagnosis of rheumatoid arthritis made by consultant rheumatologist at least 12 months previously
Description

ID.1

Type de données

boolean

current single or combination use of methotrexate, sulphasalazine and/or hydroxychloroquine
Description

ID.2

Type de données

boolean

arthritis currently in remission, as judged clinically by referring healthcare professional
Description

ID.3

Type de données

boolean

willing to consider dmard withdrawal
Description

ID.4

Type de données

boolean

Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
use of biologic therapy within the past 6 months
Description

ID.5

Type de données

boolean

received steroids within past 3 months (enteral, parenteral or intra-articular)
Description

ID.6

Type de données

boolean

use of any dmard other than methotrexate, sulphasalazine or hydroxychloroquine within the past 6 months (or past 12 months for leflunomide)
Description

ID.7

Type de données

boolean

current pregnancy, or pregnancy planned within next 6 months
Description

ID.8

Type de données

boolean

current participation within another clinical trial
Description

ID.9

Type de données

boolean

inability to provide informed consent
Description

ID.10

Type de données

boolean

Similar models

Eligibility Rheumatoid Arthritis NCT02219347

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
clinical diagnosis of rheumatoid arthritis made by consultant rheumatologist at least 12 months previously
boolean
ID.2
Item
current single or combination use of methotrexate, sulphasalazine and/or hydroxychloroquine
boolean
ID.3
Item
arthritis currently in remission, as judged clinically by referring healthcare professional
boolean
ID.4
Item
willing to consider dmard withdrawal
boolean
Item Group
C0680251 (UMLS CUI)
ID.5
Item
use of biologic therapy within the past 6 months
boolean
ID.6
Item
received steroids within past 3 months (enteral, parenteral or intra-articular)
boolean
ID.7
Item
use of any dmard other than methotrexate, sulphasalazine or hydroxychloroquine within the past 6 months (or past 12 months for leflunomide)
boolean
ID.8
Item
current pregnancy, or pregnancy planned within next 6 months
boolean
ID.9
Item
current participation within another clinical trial
boolean
ID.10
Item
inability to provide informed consent
boolean

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial